• Home
  • Search Results
  • Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy.

Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy.

Cell death & disease (2019-10-19)
Chantal Hoi Yin Cheung, Chia-Lang Hsu, Chao-Yin Tsuei, Tzu-Ting Kuo, Chen-Tsung Huang, Wen-Ming Hsu, Yun-Hsien Chung, Hsin-Yi Wu, Cheng-Chih Hsu, Hsuan-Cheng Huang, Hsueh-Fen Juan

MYCN-amplified (MNA) neuroblastoma is an aggressive neural crest-derived pediatric cancer. However, MYCN is indispensable for development and transcriptionally regulates extensive network of genes. Integrating anti-MYCN ChIP-seq and gene expression profiles of neuroblastoma patients revealed the metabolic enzymes, MTHFD2 and PAICS, required for one-carbon metabolism and purine biosynthesis were concomitantly upregulated, which were more susceptible to metastatic neuroblastoma. Moreover, we found that MYCN mediated the folate cycle via MTHFD2, which contributed one-carbon unit to enhance purine synthesis, and further regulated nucleotide production by PAICS in response to cancer progression. Dual knockdown of the MYCN-targeted gene pair, MTHFD2 and PAICS, in MNA neuroblastoma cells synergically reduced cell proliferation, colony formation, migration ability, and DNA synthesis. By systematically screening the compound perturbagens, the gene expression levels of MTHFD2 and PAICS were specifically suppressed by anisomycin and apicidin across cell lines, and our co-treatment results also displayed synergistic inhibition of MNA neuroblastoma cell proliferation. Collectively, targeting a combination of MYCN-targeted genes that interrupts the interconnection of metabolic pathways may overcome drug toxicity and improve the efficacy of current therapeutic agents in MNA neuroblastoma.

Product Number
Product Description

AICAR, ≥98% (HPLC), powder
Guanosine 5′-monophosphate disodium salt hydrate, from yeast, ≥99%
Phenazine methosulfate, ≥90% (UV)
Inosine 5′-monophosphate disodium salt hydrate, from yeast, Grade III, ≥98% (HPLC)
L-Serine, ReagentPlus®, ≥99% (HPLC)
Apicidin, ≥98% (HPLC), from microbial